This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Endpoints News
endpts.com
did:plc:l5aan5lkmuqstilgyczaho3v
#ADA25: Updated data from Novo's amycretin reveals perplexing lack of response in higher doses.
https://endpoints.news/a-puzzling-update-from-novo-nordisk-and-new-data-from-roche-at-ada25/?utm_source=Bluesky&utm_medium=organic_social&utm_campaign=editorial&utm_content=
2025-06-23T12:55:19.637Z